In ESCC, FGFR1 amplification is more prevalent than esophageal adenocarcinoma, and an overexpression of the FGFR1 gene is shown to independently predict prognosis in ESCC patients [38,39]. Here, FGFR1 is linked to esophageal adenocarcinoma.